MedTrace Logo

The VOICE-COVID-19

NCT04508972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 267

Last updated 2023-08-07

No results posted yet for this study

Summary

The VOICE-COVID study will evaluate the concordance of screening for symptoms of COVID-19 using a voice based device (Amazon Alexa) compared to manual screening by a study coordinator for individuals entering the Cardiology/Heart Failure clinic at the McGill University Health Centre.

Conditions

  • Covid19

Interventions

DEVICE

Alexa Amazon

To test the use of the Amazon Alexa device as a tool to conduct screening of employees and patients at the point of entry into the Heart Failure (HF) Clinic of the McGill University Health Center.

Sponsors & Collaborators

  • Amazon Web Services (AWS) Canada

    collaborator UNKNOWN

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    lead OTHER

Principal Investigators

  • Abhinav Sharma, MD · McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2023-03-30
Completion
2023-03-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04508972 on ClinicalTrials.gov